BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Gastrointestinal Pharmacology and Therapeutics

The World Journal of Gastrointestinal Pharmacology and Therapeutics (WJGPT) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of gastrointestinal pharmacology and therapeutics.  It was launched on February 6, 2010 and is published trimonthly (4 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage pharmacology and therapeutics specialists worldwide to submit manuscripts to the WJGPT describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJGPT are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJGPT’s acceptance rate: 49%.  Submit here >>

2017 Published Issues
3 2 1
Editors-in-Chief
  • Hugh J Freeman, FACG, FACP, FRCP(C), MD, Professor, (E-mail:hugfree@shaw.ca)Department of Medicine (Gastroenterology) , University of British Columbia, and Senior Active Staff, Vancouver General Hospital and UBC Health Sciences Center Hospital, Vancouver V6T 1W5, British Columbia, Canada
Indexing/Abstracting
PubMed, PubMed Central.
Journal Metrics
There is currently no impact factor.
ISSN
2150-5349 (online)
Editorial
Strategies for overcoming anti-tumor necrosis factor drug antibodies in inflammatory bowel disease: Case series and review of literature 
Mansi M Kothari, Douglas L Nguyen, Nimisha K Parekh 
World J Gastrointest Pharmacol Ther 8(3):155-161. Published online Aug 6, 2017. doi: 10.4292/wjgpt.v8.i3.155
Review
Phage therapy: An alternative to antibiotics in the age of multi-drug resistance 
Derek M Lin, Britt Koskella, Henry C Lin 
World J Gastrointest Pharmacol Ther 8(3):162-173. Published online Aug 6, 2017. doi: 10.4292/wjgpt.v8.i3.162
Minireviews
Critically ill patients and gut motility: Are we addressing it? 
Alfredo Vazquez-Sandoval, Shekhar Ghamande, Salim Surani 
World J Gastrointest Pharmacol Ther 8(3):174-179. Published online Aug 6, 2017. doi: 10.4292/wjgpt.v8.i3.174
Retrospective Study
Use of proton pump inhibitors in general practice 
Cesare Tosetti, Ilaria Nanni 
World J Gastrointest Pharmacol Ther 8(3):180-185. Published online Aug 6, 2017. doi: 10.4292/wjgpt.v8.i3.180
Observational Study
Transition care in inflammatory bowel disease: A needs assessment survey of Quebec gastroenterologists and allied nurses 
Matthew Strohl, Xun Zhang, Dominique Lévesque, Talat Bessissow 
World J Gastrointest Pharmacol Ther 8(3):186-192. Published online Aug 6, 2017. doi: 10.4292/wjgpt.v8.i3.186